BioCryst (BCRX) Sees Upside; No Poultry Contact Reported in Large Amount of Bird Flu Cases
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Join SI Premium – FREE
BioCryst Pharma (Nasdaq: BCRX) is moving higher again Wednesday following reports that the bird flu might not even be transferred via the main culprit: birds.
The World Health Organization (WHO) said that a number of new cases tied to the H7N9 virus haven't had a history of being in contact with poultry. The announcement confirms earlier speculation by one top Chinese scientist that 40 percent of those infected had no poultry contact.
About 16 deaths have been reported recently over avian flu. Shares of BioCryst are up about 2 percent early.
The World Health Organization (WHO) said that a number of new cases tied to the H7N9 virus haven't had a history of being in contact with poultry. The announcement confirms earlier speculation by one top Chinese scientist that 40 percent of those infected had no poultry contact.
About 16 deaths have been reported recently over avian flu. Shares of BioCryst are up about 2 percent early.
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
